Unlocking the next wave of synthetic biology

Unlocking the next wave of synthetic biology

Synthetic biology is the field where the twin disciplines of technology and biology meet.  Since the sequencing of the first human genome in the early 2000s, the first wave of synbio, our ability to “read DNA”, has advanced at a pace that has outstripped even Moore’s Law.

As this $20bn market matured, a second wave of synbio, driven by new technologies such as CRISPR gene editing, gave us an ability to “write DNA”.  This market stands today at well over $5bn and continues to grow apace as greater precision allows us to more controllably design biological systems.

The third wave of synbio has seen us begin to “apply DNA”, for example in the discovery of highly effective precision medicines.  However, it is widely known that these exquisite bioproducts are not readily accessible due to prohibitive costs and wide ranging manufacturing issues.  The solution lies far beyond the constraints of existing platforms.
Image

The fourth wave of synbio will be our ability to “scale DNA” – to apply our knowledge of reading, writing and applying DNA at an industrial scale that delivers genuinely global benefit for society.  This fourth wave has the potential to create billions of dollars of disruptive value in existing and new applications such as precision medicine, cell based agriculture, biofuels and decarbonisation.  These promise of major benefits to some of the most pressing needs of society including health, climate change and sustainability.

However, this growth is severely constrained by a “tyranny of numbers” from poorly integrated platforms.

The BiologIC team believes life would be better if we could all benefit from the latest breakthroughs in food, fuels and medicines.  Our novel and proprietary digital architectures are enabling and powering the four waves of synbio.

We are passionate about working with like-minded pioneers and warmly invite you to join our mission by contacting us at: This email address is being protected from spambots. You need JavaScript enabled to view it.

To discover more about these topics, please explore our blogs.